ENTA · Enanta Pharmaceuticals Inc
$12.45
-0.16 (-1.27%)
At close · Jul 29
Market Cap
$362.03M
Shares
29.08M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-07-02 | $75,000,000 | — | — | — | 8-K , filed 2026-07-02 |
Key facts
CIK
1177648
CUSIP
29251M106
13F (30d)
38 filings
17 filers
Visit website
Investor relations